Respiratory & Pulmonary Division
How Can We Help?
We offer specialized clinical trial management and cutting-edge research to advance treatments across diverse therapeutic areas.
Breathing Life Into Pulmonary Research
Respiratory diseases, both chronic and acute, affect millions worldwide, from asthma to more severe conditions like chronic obstructive pulmonary disease (COPD) and interstitial lung diseases. CTR’s Respiratory & Pulmonary Division is focused on driving research that can deliver life-changing treatments to patients dealing with these often-debilitating conditions. Our expertise spans both common respiratory issues and rare pulmonary diseases, ensuring that no patient group is overlooked.
Key Focus Areas:
- Chronic Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hypertension, Bronchitis
- Interstitial & Fibrotic Lung Diseases: Idiopathic Pulmonary Fibrosis (IPF), Interstitial Lung Disease (ILD)
- Respiratory Infections: Pneumonia, Tuberculosis, COVID-19, RSV (Respiratory syncytial virus)
- Rare Pulmonary Disorders: Cystic Fibrosis, Pulmonary Sarcoidosis
Our Approach
Using telemedicine, remote monitoring, and virtual visits, we make it easier for patients to participate in trials while maintaining rigorous data collection standards. Our high-touch approach helps keep patients engaged, while ensuring that data is accurate and reliable.